Drug profile

The FDA adverse-event record for Electrolytes

41 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Electrolytes. See the species affected, top reactions, and outcomes below.

41
adverse-event reports
53.7%
death-coded share
Dog
most-reported species
15
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
41
Total Reports
22
Deaths Reported
53.7%
Death Rate

Active Ingredients

Electrolytes

Administration Routes

UnknownOralIntravenousSubcutaneous

Species Affected

Dog 22
Cat 10
Horse 7
Cattle 2

Most Affected Breeds

Retriever - Labrador 6
Domestic Shorthair 4
Mixed (Dog) 2
Shepherd Dog - German 2
Maltese 2
Retriever - Golden 2
Domestic Mediumhair 2
Abyssinian cat 1
Arab 1
Quarter Horse 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 15
Death 13
Vomiting 9
Anorexia 9
Death by euthanasia 8
Anaemia NOS 7
Weight loss 7
Seizure NOS 6
Depression 6
Elevated total bilirubin 6
Behavioural disorder NOS 5
Pale mucous membrane 5

Outcome Breakdown

Died
14 (34.1%)
Ongoing
9 (22.0%)
Euthanized
8 (19.5%)
Recovered/Normal
7 (17.1%)
Outcome Unknown
3 (7.3%)

Electrolytes Adverse Event Insights

41 reports name Electrolytes; 22 recorded a death outcome (53.7% of reported events, not a population-level mortality rate). Active ingredient: Electrolytes. Administration routes: Unknown, Oral, Intravenous, Subcutaneous.

By species: Dog (22 reports), Cat (10 reports), Horse (7 reports). By breed: Retriever - Labrador (6), Domestic Shorthair (4), Mixed (Dog) (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (15), Death (13), Vomiting (9), Anorexia (9). Outcome, 41 coded reports: Died leads at 34.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.